Related Experiment Video
Updated: Nov 17, 2025
Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells
Published on: June 9, 2020
Mumps in Poland in 2018
Joanna Bogusz1, Iwona Paradowska-Stankiewicz1
1National Institute of Public Health - National Institute of Hygiene, Department of Epidemiology of Infectious Diseases and Surveillance.
Introduction:
Vaccination against mumps from 2003 is mandatory in Poland and given as two dose scheme with MMR vaccine (mumps, measles, and rubella). Earlier this vaccination was only recommended. Despite observed decline in mumps incidence for over a decade which is a result of conducted vaccinations, mumps is still a common disease among the children.
Aim:
To assess epidemiological situation of mumps in Poland in 2018, including vaccination coverage in Polish population, in comparison to previous years.
Methods:
The descriptive analysis was based on data retrieved from routine mandatory surveillance system and published in the annual bulletins "Infectious diseases and poisonings in Poland in 2018" and "Vaccinations in Poland in 2018".
Results:
In total, there were 1 585 mumps cases registered in Poland in 2018. Incidence of mumps was 4.1 per 100,000 and it was lower in comparison with 2017. The highest incidence (6.6 per 100 000) was registered in Opolskie voivodeship and the lowest (2.6) - in Warmińsko-mazurskie voivodeship. The highest incidence rate was observed among children aged 5 years (39.2 per 100 000). Incidence in men (5.0 per 100 000) was higher than in women (3.4). In 2018, 28 people were hospitalized due to mumps. Vaccination coverage of children aged 3 years in Poland in 2018 was 92,9% and it was lower by 1.1% in comparison with year 2017.
Conclusions:
Systematic execution of mumps vaccination in accordance with the National Immunisation Programme resulted in a significant decrease in the number of registered cases. Due to the high vaccination coverage further decline in the number of cases is expected.
Insights
Mandatory mumps vaccination in Poland has significantly reduced cases. Despite a slight dip in 2018 vaccination coverage, continued high immunization rates are expected to further decrease mumps incidence.
Area of Science:
- Epidemiology
- Public Health
- Immunization Practices
Background:
- Mumps vaccination, using the MMR vaccine (mumps, measles, and rubella), has been mandatory in Poland since 2003 with a two-dose schedule.
- While vaccination has led to a decade-long decline in mumps incidence, the disease remains prevalent among children.
Purpose of the Study:
- To evaluate the epidemiological status of mumps in Poland during 2018.
- To assess mumps vaccination coverage within the Polish population and compare it with previous years.
Main Methods:
- A descriptive analysis was conducted using data from Poland's mandatory surveillance system.
- Data were sourced from the "Infectious diseases and poisonings in Poland in 2018" and "Vaccinations in Poland in 2018" annual bulletins.
Main Results:
- In 2018, Poland registered 1,585 mumps cases, with an incidence of 4.1 per 100,000 population, a decrease from 2017.
- The highest incidence was observed in 5-year-old children (39.2 per 100,000), with higher rates in men (5.0) than women (3.4).
- Mumps vaccination coverage for 3-year-olds in 2018 was 92.9%, a 1.1% decrease compared to 2017.
Conclusions:
- Consistent implementation of the National Immunisation Programme for mumps has resulted in a substantial reduction in reported cases.
- High vaccination coverage is anticipated to lead to a continued decrease in mumps cases in the future.
